Trading Ideas Summit Therapeutics Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 19:51:31 12/01/2026 GMT			5-day change	1st Jan Change
17.48 ^USD	-11.20%		-0.46%	-0.74%

07:07pm	Summit Therapeutics Inc. Announces Submission of Biologics License Application to U.S. FDA Seeking Approval for Ivonescimab in Combination with Chemotherapy in 2L+ Treatment of Patients with EGFRm NSCLC	CI
06:50pm	Summit Therapeutics Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 09:45 AM

No results for this search